Ondine Biomedical Inc.

Transaction in Own Shares • Nov 4, 2022

National Storage Mechanism | Additional information

RNS Number : 2949F

Ondine Biomedical Inc.

04 November 2022

4 November 2022

Ondine Biomedical Inc.

("Ondine Biomedical", "Ondine" or the "Company")

PDMR Dealing

Ondine Biomedical Inc. (AIM: OBI), announces the following dealings a person discharging managerial responsibilities ('PDMR'):

On 2 November 2022, Vipul Shah, Chief Financial Officer of Ondine, purchased 15,000 ordinary shares with no par value at a price of 24.5 pence per share. Following this purchase, Mr Shah's total interest in the Company is 65,000 Ordinary Shares, representing 0.033% of the total voting rights of the Company.

The notification below, made in accordance with the requirements of the UK Market Abuse Regulations, provides further detail in respect of the transaction as described above.

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Vipul Shah

2.

Reason for the Notification

a)

Position/status

Chief Financial Officer

b)

Initial notification/amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Ondine Biomedical Inc.

b)

LEI

9845005B69E07CGF4A56

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv)each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares of no par value

Identification code

GB00BYX5K988

b)

Nature of the Transaction

Purchase of ordinary shares

c)

Price(s) and volume(s)

Price(s)	Volume(s)
24.5 pence	15,000

d)

Aggregated information

Aggregated volume Price

As above

e)

Date of the transaction

2.11.2022

f)

Place of the transaction

AIM (LSE)

For further Information, please visit: www.ondinebio.com or contact:

Ondine Biomedical Inc.
Carolyn Cross, CEO	+1 604 669 0555
Strand Hanson Limited (Nominated and Financial Adviser)
James Harris, James Dance, Richard Johnson	+44 (0) 20 7409 3494
RBC Capital Markets (Joint Broker)
Rupert Walford, Kathryn Deegan	+44 (0) 20 7653 4000
Singer Capital Markets (Joint Broker)
Aubrey Powell, Asha Chotai	+44 (0)20 7496 3000
Vane Percy & Roberts (Media Contact)
Simon Vane Percy, Amanda Bernard	+44 (0) 77 1000 5910

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHBJBTTMTAMTLT